Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow metastases

E J Shpall1, A P Gee, C Hogan

  • 1Bone Marrow Transplant Program, University of Colorado, Denver, USA.

Hematology/Oncology Clinics of North America
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A perspective on ABO incompatible transplantation.

Human immunology·2026
Same author

An examination of the use of standard operating procedures on family-operated farms.

JDS communications·2025
Same author

The factors contributing to better workplaces for farmers on pasture-based dairy farms.

Journal of dairy science·2024
Same author

An examination of labor time-use on spring-calving dairy farms in Ireland.

Journal of dairy science·2022
Same author

Estimating the effect of different work practices and technologies on labor efficiency within pasture-based dairy systems.

Journal of dairy science·2022
Same author

Potassium titanyl phosphate laser surface tympanoplasty as a novel treatment for chronic granular myringitis in a series of 14 patients.

The Journal of laryngology and otology·2021
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

This article reviews detecting bone marrow metastases and eradicating cancer cells in patients undergoing hematopoietic cell autografts. It highlights current methods and emerging strategies for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Hematology

Background:

  • Bone marrow metastases represent a significant clinical challenge in cancer progression.
  • Accurate detection of tumor cells in the marrow is crucial for staging and treatment planning.

Purpose of the Study:

  • To discuss the clinical significance of bone marrow metastases.
  • To review current methods for detecting tumor cells in bone marrow.
  • To examine strategies for eradicating cancer cells from marrow in patients undergoing hematopoietic cell autografts.

Main Methods:

  • Review of existing literature on bone marrow metastasis detection.
  • Analysis of current diagnostic techniques for tumor cell identification in marrow.
  • Evaluation of investigational approaches for cancer cell eradication in autograft recipients.

Related Experiment Videos

Main Results:

  • Bone marrow metastases impact patient prognosis and treatment response.
  • Various methods exist for detecting tumor cells, with ongoing advancements.
  • Strategies for marrow decontamination are under investigation for autologous transplantation.

Conclusions:

  • Effective detection and eradication of bone marrow metastases are vital for successful cancer therapy.
  • Further research into novel detection and elimination techniques is warranted.
  • Optimizing marrow purging strategies can improve outcomes for patients receiving hematopoietic cell autografts.